Measles and Rubella (MR) Vaccine

About Micron Biomedical

Micron Biomedical is a private, clinical-stage biotech based in Atlanta, GA, founded in 2013. The company is advancing a novel dissolvable microarray platform for the needle-free delivery of vaccines and therapeutics, designed to be painless, thermostable, and suitable for self-administration. With significant non-dilutive grant funding and partnerships with major global health organizations, Micron is progressing multiple programs, including vaccines for rotavirus, measles/rubella, and influenza, into clinical trials. Its technology addresses critical challenges in global health, including cold chain dependence, need for trained personnel, and vaccine hesitancy.

Therapeutic Areas